Pfizer (PFE) FCF Margin Growth (5y) (2014 - 2026)

Pfizer (PFE) FCF Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 6,571.00
Sep 28, 2025 12,593.00
Jun 29, 2025 -9,412.00
Mar 30, 2025 6,689.00
Sep 29, 2024 88,088.00
Jun 30, 2024 -3,428.00
Mar 31, 2024 -684.00
Dec 31, 2023 36,816.00
Oct 1, 2023 12,542.00
Jul 2, 2023 -8,622.00
Apr 2, 2023 -1,036.00
Oct 2, 2022 4,779.00
Jul 3, 2022 509.00
Apr 3, 2022 1,339.00
Oct 3, 2021 7,220.00
Jul 4, 2021 3,257.00
Apr 4, 2021 1,586.00
Sep 27, 2020 903.00
Jun 28, 2020 899.00
Mar 29, 2020 1,286.00